Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Brain Neoplasms 8 Cognitive Dysfunction 4 Radiation Injuries 3 Multiple Myeloma 2 Lymphoma 2 Glioma 2 Triple Negative Breast Neoplasms 1 Stroke 1 Parkinson Disease 1 Neoplasms 1 Medulloblastoma 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphoma, B-Cell 1 Localized, Operable Non-small Cell Lung Cancer 1 Liver Neoplasms 1 Liver Diseases 1 Infratentorial Neoplasms 1 Glioblastoma 1 Fibrosis 1 Fatigue 1 Epilepsy 1 Colorectal Neoplasms 1 Cancer Related Cognitive Difficulties 1 Breast Neoplasms 1 Brain Injuries, Traumatic 1 Astrocytoma 1

Interventions

ziprasidone 1 enzalutamide 1 Zolpidem 1 Warfarin 1 Vecuronium Bromide 1 Vancomycin 1 Tranexamic Acid 1 Tobramycin 1 Surgical Procedures, Operative 1 Spironolactone 1 Sevelamer 1 Rocuronium 1 Registries 1 Piperacillin, Tazobactam Drug Combination 1 Pentobarbital 1 Oxycodone 1 Nifedipine 1 Neuropsychological Tests 1 Nafcillin 1 Molindone 1 Methylprednisolone 1 Medical Marijuana 1 Mass Screening 1 Magnetoencephalography 1 Lurasidone Hydrochloride 1 Labetalol 1 Histocompatibility Testing 1 Haloperidol 1 Fosfomycin 1 Clozapine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Epilepsy × Neuropsychological Tests × Clear all

NCT02320136 2023-12-01

HFO

University of Zurich

Epilepsy, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡